← Eichor
Condition: Growth Hormone Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Growth Hormone

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short
Phase 3 · 32 location(s) · Rabin Medical Center · NCT07226089A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
Phase N/A · 4 location(s) · Pfizer · NCT06587035KETOgenic Diet Therapy in Patients With ACROmegaly
NA · 1 location(s) · Erasmus Medical Center · NCT06949891Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Phase N/A · 1 location(s) · LG Chem · NCT01604395ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
Phase 2 · 45 location(s) · Alexion Pharmaceuticals, Inc. · NCT07037420Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficien
Phase 3 · 16 location(s) · VA Office of Research and Development · NCT04867317Evaluation of the Propensity of Patients Under rhGH to Envision a Modification of Their Treatment Regimen Toward LAGH
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06542809The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
Phase 3 · 49 location(s) · Xiamen Amoytop Biotech Co., Ltd. · NCT07309562A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treat
Phase 2 · 36 location(s) · BioMarin Pharmaceutical · NCT06668805Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Phase N/A · 1 location(s) · Dong-A ST Co., Ltd. · NCT04798690Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stag
Phase 2 · 17 location(s) · Merck Sharp & Dohme LLC · NCT06797635Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 13 location(s) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT05985655Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
Phase 2 · 2 location(s) · Baylor College of Medicine · NCT05355272Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT07546695Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of
Phase N/A · 1 location(s) · ART Fertility Clinics LLC · NCT06732843The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
Phase 3 · 38 location(s) · Xiamen Amoytop Biotech Co., Ltd. · NCT06927310Growth Hormone for the Treatment of Gastroparesis
EARLY_Phase 1 · 2 location(s) · Mayo Clinic · NCT06803589Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
Phase 3 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05212454Growth Hormone Resistance of Beta-cells A
Phase N/A · 1 location(s) · University of Missouri-Columbia · NCT06571487Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 N
Phase 2 · 13 location(s) · TransThera Sciences (Nanjing), Inc. · NCT07498478NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.
Phase N/A · 1 location(s) · Henan Cancer Hospital · NCT06781281A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Meta
Phase 2 · 53 location(s) · Puma Biotechnology, Inc. · NCT06369285Effect of GH on the Blastocyst Euploid Rate in AMA Patients
Phase 3 · 1 location(s) · ShangHai Ji Ai Genetics & IVF Institute · NCT05447208A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Phase N/A · 27 location(s) · Ascendis Pharma Endocrinology Division A/S · NCT05820672Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for
NA · 1 location(s) · Medical College of Wisconsin · NCT06106477Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 3 · 229 location(s) · Novartis Pharmaceuticals · NCT05827081A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmaco
Phase 2 · 1 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07260500A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Rec
Phase 2 · 1 location(s) · Zhejiang Cancer Hospital · NCT07330544Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
Phase N/A · 1 location(s) · Wenjin Yin · NCT07180056Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
Phase 2 · 1 location(s) · Wenjin Yin · NCT07180160
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.